Literature DB >> 27481656

Nanofibrous polymeric beads from aramid fibers for efficient bilirubin removal.

Zihang Peng1, Ye Yang1, Jiyue Luo1, Chuanxiong Nie1, Lang Ma1, Chong Cheng2, Changsheng Zhao3.   

Abstract

Polymer based hemoperfusion has been developed as an effective therapy to remove the extra bilirubin from patients. However, the currently applied materials suffer from either low removal efficiency or poor blood compatibility. In this study, we report the development of a new class of nanofibrous absorbent that exhibited high bilirubin removal efficiency and good blood compatibility. The Kevlar nanofiber was prepared by dissolving micron-sized Kevlar fiber in proper solvent, and the beads were prepared by dropping Kevlar nanofiber solutions into ethanol. Owing to the nanofiborous structure of the Kevlar nanofiber, the beads displayed porous structures and large specific areas, which would facilitate the adsorption of toxins. In the adsorption test, it was noticed that the beads possessed an adsorption capacity higher than 40 mg g(-1) towards bilirubin. In plasma mimetic solutions, the beads still showed high bilirubin removal efficiency. Furthermore, after incorporating with carbon nanotubes, the beads were found to have increased adsorption capacity for human degradation waste. Moreover, the beads showed excellent blood compatibility in terms of a low hemolysis ratio, prolonged clotting times, suppressed coagulant activation, limited platelet activation, and inhibited blood related inflammatory activation. Additionally, the beads showed good compatibility with endothelial cells. In general, the Kevlar nanofiber beads, which integrated with high adsorption capacity, good blood compatibility and low cytotoxicity, may have great potential for hemoperfusion and some other applications in biomedical fields.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27481656     DOI: 10.1039/c6bm00328a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  3 in total

Review 1.  Recent trends in therapeutic application of engineered blood purification materials for kidney disease.

Authors:  Cui Gao; Qian Zhang; Yi Yang; Yangyang Li; Weiqiang Lin
Journal:  Biomater Res       Date:  2022-02-04

2.  A breakthrough trial of an artificial liver without systemic heparinization in hyperbilirubinemia beagle models.

Authors:  Yilin Wang; Shanshan Wang; Xueqin He; Yupei Li; Tao Xu; Lin Xu; Bo Yang; Xinnian Fan; Weifeng Zhao; Changsheng Zhao
Journal:  Bioact Mater       Date:  2022-07-06

3.  Ultrafast formation of ANFs with kinetic advantage and new insight into the mechanism.

Authors:  Lianqing Huang; Meiyun Zhang; Jingyi Nie; Bin Yang; Jiaojun Tan; Shunxi Song
Journal:  Nanoscale Adv       Date:  2022-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.